← Open Payments lookup

ANA RAYGOZA: Open Payments

NPI 1437313913 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,933 in 108 payments from 18 companies in 2025. Trend: 2023 $1,716 · 2024 $2,063 · 2025 $1,933

Food & beverage: $1,933
CompanyPaymentsAmount
ABBVIE INC.29$451
Janssen Biotech, Inc.24$419
Salix Pharmaceuticals, a division of Bausch Health US, LLC17$298
Lilly USA, LLC8$154
Celltrion USA Inc.5$116
Ardelyx, Inc.4$89
Takeda Pharmaceuticals U.S.A., Inc.3$63
Novo Nordisk Inc3$54
Gilead Sciences, Inc.2$52
Ipsen Biopharmaceuticals, Inc3$48

Products named: TREMFYA, XIFAXAN, LINZESS, RINVOQ, OMVOH, VEGZELMA, IBSRELA, EOHILIA.

Industry payments across TX — which companies pay providers there.